Does ASFOTASE ALFA Cause Lipodystrophy acquired? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Lipodystrophy acquired have been filed in association with ASFOTASE ALFA (STRENSIQ). This represents 0.8% of all adverse event reports for ASFOTASE ALFA.
68
Reports of Lipodystrophy acquired with ASFOTASE ALFA
0.8%
of all ASFOTASE ALFA reports
0
Deaths
2
Hospitalizations
How Dangerous Is Lipodystrophy acquired From ASFOTASE ALFA?
Of the 68 reports, 2 (2.9%) required hospitalization.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASFOTASE ALFA. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does ASFOTASE ALFA Cause?
Injection site pain (1,227)
Injection site erythema (828)
Fatigue (759)
Pain (673)
Injection site reaction (659)
Arthralgia (524)
Injection site bruising (469)
Pain in extremity (463)
Injection site swelling (417)
Headache (322)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which ASFOTASE ALFA Alternatives Have Lower Lipodystrophy acquired Risk?
ASFOTASE ALFA vs ASIAN GINSENG
ASFOTASE ALFA vs ASMANEX TWISTHALER
ASFOTASE ALFA vs ASPARAGINASE
ASFOTASE ALFA vs ASPARAGINASE ERWINIA CHRYSANTHEMI
ASFOTASE ALFA vs ASPARAGINASE ERWINIA CHRYSANTHEMI -RYWN